Statins for the primary prevention of cardiovascular events in elderly patients:: A picture from clinical practice without strong evidence from clinical trials

被引：11
|
作者：
Trifiro, Gianluca [1 ]
Alacqua, Marianne [1 ]
Corrao, Salvatore [3 ]
Tari, Michele [2 ]
Arcoraci, Vincenzo [1 ]
机构：
[1] Univ Messina, Dept Clin & Expt Med & Pharmacol, IRCCS Ctr Neurol Bonino Pulejo, Messina, Italy
[2] Caserta Local Hlth Serv 1, Caserta, Italy
[3] Univ Palermo, Biomed Dept Internal Med & Subspecialties, Palermo, Italy
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2008年 / 56卷 / 01期
关键词：
D O I：
10.1111/j.1532-5415.2007.01486.x
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：175 / 177
页数：4
相关论文
共 50 条
  • [1] Statins and Elderly: From Clinical Trials to Daily Practice
    Verdoia, Monica
    Galasso, Gennaro
    Filardi, Pasquale Perrone
    De Luca, Giuseppe
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (03) : 233 - 238
  • [2] Statins for Primary Prevention of Cardiovascular Disease Review of Evidence and Recommendations for Clinical Practice
    Kazi, Dhruv S.
    Penko, Joanne M.
    Bibbins-Domingo, Kirsten
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2017, 101 (04) : 689 - +
  • [3] Statins Reduce Cardiovascular Events in Primary and Secondary Prevention Trials without Causing an Increase in Carcinoma
    Aronow, Wilbert S.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (10) : 1942 - 1943
  • [4] Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events-a cohort study in 395 039 patients from clinical practice
    Motsko, Stephen P.
    Russmann, Stefan
    Ming, Eileen E.
    Singh, Varinder P.
    Vendiola, Ruby M.
    Jones, Judith K.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (12) : 1214 - 1222
  • [5] Aggressive lipid management for cardiovascular prevention: Evidence from clinical trials
    Friday, KE
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (07) : 769 - 778
  • [6] Aspirin for the Prevention of Cardiovascular Events in Patients without Clinical Cardiovascular Disease: a Meta-Analysis of Randomized Trials
    Lala, Anuradha
    Krantz, Mori J.
    Baker, Gizelle S.
    Hiatt, William R.
    Berger, Jeffrey S.
    [J]. CIRCULATION, 2010, 122 (21)
  • [7] Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials
    Berger, Jeffrey S.
    Lala, Anuradha
    Krantz, Mori J.
    Baker, Gizelle S.
    Hiatt, William R.
    [J]. AMERICAN HEART JOURNAL, 2011, 162 (01) : 115 - U159
  • [8] Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice
    Bruckert, Eric
    Ferrieres, Jean
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES, 2014, 107 (03) : 188 - 200
  • [9] Impact of secondary prevention on survival in patients with stroke: from clinical trials to clinical practice
    Bejot, Yannick
    Giroud, Maurice
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (04): : 356 - 356
  • [10] Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Older Adults: A Survival Meta-analysis of Randomized Clinical Trials
    Yourman, L.
    Nguyen, B.
    Rodriguez, A.
    Cenzer, I.
    Lee, S.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S58 - S58
12345